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Abstract
Background: There is increasing interest in building the capacity of researchers in low and middle income
countries (LMIC) to address their national priority health and health policy problems. However, the number and
variety of partnerships and funding arrangements can create management problems for LMIC research institutes.
This paper aims to identify problems faced by a health research institute in Bangladesh, describe two strategies
developed to address these problems, and identify the results after three years of implementation.
Methods: This paper uses a mixture of quantitative and qualitative data collected during independent annual
reviews of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) between 2006 and 2010.
Quantitative data includes the number of research activities according to strategic priority areas, revenues collected
and expenditure. Qualitative data includes interviews of researchers and management of ICDDR,B, and of research
users and key donors. Data in a Monitoring and Evaluation Framework (MEF) were assessed against agreed
indicators.
Results: The key problems faced by ICDDR,B in 2006 were insufficient core funds to build research capacity and
supporting infrastructure, and an inability to direct research funds towards the identified research priorities in its
strategic plan. Two strategies were developed to address these problems: a group of donors agreed to provide
unearmarked pooled core funding, and accept a single common report based on an agreed MEF. On review after
three years, there had been significant increases in total revenue, and the ability to allocate greater amounts of
money on capacity building and infrastructure. The MEF demonstrated progress against strategic objectives, and
better alignment of research against strategic priorities. There had also been changes in the sense of ownership
and collaboration between ICDDR,B’s management and its core donors.
Conclusions: The changes made to funding relationships supported and monitored by an effective MEF enabled
the organisation to better align funding with research priorities and to invest in capacity building. This paper
identified key issues for capacity building for health research in low and middle income countries. The findings
have relevance to other research institutes in similar contexts to advocate and support research capacity
strengthening efforts.
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evaluation, and core funding
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Background
Strengthening research capacity is considered one of the
most powerful, cost-effective, and sustainable means of
advancing health and development [1]. In the last two
decades, there has been an increased interest in building
and assessing health research capacity in developing
countries [2-10]. Capacity for health research is defined
as ‘an ability of individuals, organisations, or systems to
perform and utilise health research effectively, efficiently,
and sustainably’ [11]. This definition includes research
capacity at the level of individuals (training), organisa-
tions and systems.
According to Nchinda [2002], research capacity
strengthening consists of two main, closely inter-related
and inter-dependent activities: providing institutional sup-
port, and improving researcher capacity through appropri-
ate training. Building research capacity requires political
will and credibility, a responsive capacity-building plan,
leveraging, and cost sharing [2,12,13]. Research capacity is
still one of the constraints that prevents institutions in
developing countries from engaging in effective and essen-
tial research [5]. Building capacity for health research is a
complex and long-term process [1]. Inadequate support,
poor management and negative influences associated with
other external or internal factors can damage the research
capacities of institutions [1]. One of the factors required
for effective research infrastructure is the provision of
appropriate facilities that support researchers [14]. Finan-
cial and intellectual supports are also essential for building
effective and sustainable research institutions [15].
Trostle and Simon (1992) argued that research capacity
building is a development goal influenced by structural
constraints and cultural impediments among both donors
and recipients. Strengthening research capacity is mainly
an initiative of donor agencies located in developed coun-
tries [17,18]. However, the WHO, the Commission on
Health Research for Development, the Global Forum on
Health Research, the International Clinical Epidemiology
Network and other international agencies continue to
emphasise the need to strengthen capacity of research
institutions in developing countries [12,19-24].
A number of authors have highlighted the importance
of a favourable and conducive enabling environment for
research, in addition to good physical infrastructure
[1,10,25-27]. This includes factors such as: adequate
funds for researcher and staff salaries; training of indivi-
dual researchers; career structure for researchers; good
research management; equitable access to scientific and
technical information; partnerships between developed
and developing countries; establishment of effective
interfaces between research producers and users; and
competent and motivated institutional leaders. These
are the key challenges to building research capacity in
developing countries.
Strengthening research capacity in developing coun-
tries is heavily dependent upon external investment [24].
Lansang and Dennis (2004) identify the need for greater
investment in research capacity building in developing
countries, and irrespective of the source, ‘a good propor-
tion is allocated to capacity building’. They suggest the
need to ‘document and analyse success and lessons
learnt from countries and organisations that have
devised innovative financing schemes for health
research’.
Mayhew et al. (2008) concluded that capacity building
cannot be achieved without substantial financial input
and recommended that development partners should
provide long-term and in-country support for successful
research capacity building. Development partners need to
be focused and make coordinated efforts to achieve maxi-
mal effect. Further research is needed to identify the best
funding support to build capacity for research [28].
Simon J (2000) supported strengthening health
research capacity building in developing countries. He
pointed out that that there is little information available
on the impact of millions of dollars of investments for
building research capacity and indeed, little has been
written on how research capacity development efforts
can be monitored and evaluated. There is a lack of agreed
indicators for measuring progress or achievement, which
are crucial to evaluate the impact of investments on
research capacity. There is also a need to document the
results and impacts of different kinds of investment for
development partners and policy makers [29].
ICDDR,B
The International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) is a well established
international health research institute focusing primarily
on research that offers data for a wide range of disease
areas to help decision makers, especially in public
health. Although the information published and dissemi-
nated by ICDDR,B has global utility, it specifically
focuses on health issues that are more relevant to low
income countries. Since its establishment in 1960,
ICDDR,B has been the recipient of significant amounts
of international donor funding to support its develop-
ment and research projects. Over the past 50 years, the
organisation has made significant contributions to
expanding knowledge and service delivery practice in
health; in particular the development and introduction
of oral rehydration solution (ORS) for severe diarrhoea.
Despite valuable and constant financial support, a
review in 2006 observed that ICDDR,B faced a number
of challenges in managing international funding in
terms of maintaining sustainable development and sus-
tained research contributions. The following article aims
to assess whether the interventions in management of
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donor support implemented in response to the review
had enabled ICDDR,B to satisfactorily address these pro-
blems after three years
Methods
This research is based on a mixture of qualitative and
quantitative methods, using a case study approach. Qua-
litative data include key informant interviews as well as
a series of questionnaires with managers and key
researchers at ICDDR,B; with other research collabora-
tors; key funders; and potential users of research output,
including policy makers within the Ministry of Health,
Government of Bangladesh, and other national and
international development organisations operating in the
health sector. The research output from the organisation
was assessed in terms of coverage of identified research
priority areas, and the extent to which the research
addressed different phases of the development of inter-
ventions: basic and epidemiological research; causative
research; intervention research; and evaluation of imple-
mentation of interventions.
Quantitative data included counts of research outputs
and publications, patients treated at ICDDR,B’s clinical
facilities, and numbers attending training courses and
sessions. It also included an analysis of ICDDR,B’s
finances, including income and expenditure. Data
sources included: (a) Annual reports published by
ICDDR,B for the years 2006-2010; (b) Monitoring and
evaluation reports prepared by the Monitoring and Eva-
luation Unit of the organisation based on the indicators
in the agreed Monitoring and Evaluation Framework
(years 2007-2009); and (c) Annual external reviews of
ICDDR,B conducted by independent consultants for the
years 2006 to 2009. (Author KH was the independent
consultant for the reviews of 2006 and 2010). During
the reviews, qualitative data was collected through inter-
views, and the assessments and reports prepared by the
ME Unit of performance against MEF indicators were
reviewed. A summary of study areas of focus and data
sources is provided in Table 1
The ICDDR,B Monitoring and Evaluation Unit was
established in August 2007 with one coordinator and a
core team of four assistants liaising with designated divi-
sional staff who facilitate the compilation of requisite
information from the Principal Investigators (PIs). The
Unit collects, compiles and reports the data required to
assess the performance indicators included in the MEF.
Data were collected via a series of questionnaires devel-
oped by the MEF unit and entered by the designated
divisional staff onto a computer entry form.
Collated data were then meticulously analysed, modi-
fied or deleted by the MEF coordinator with the agree-
ment of the respective PI to avoid confounders and the
resulting information applied to the MEF tables. A final
scrutiny of the tables was carried out by the directors of
one of ICDDR,B’s four scientific divisions before sharing
with the core donors. From the pilot MEF in 2006, this
process was repeated each year and reports registered
and archived. The 2010 review evaluated the reports
from 2007, 2008 and 2009.
Results
Scope of activities undertaken by ICDDR,B
ICDDR,B is an international health research organisa-
tion located in Dhaka, Bangladesh. Founded in 1960 as
the Pak-SEATO Cholera Research Laboratory, it was
established as an international organisation by an ordi-
nance of the Government of Bangladesh in 1978. It was
originally focused on cholera and other diarrhoeal dis-
eases, and related problems of nutrition and family plan-
ning. Since then, its scope has broadened to include
many of the major public health disciplines and issues
facing poor countries: child health, infectious disease
and vaccine sciences, reproductive health, nutrition,
population sciences, health systems research, safe water,
food safety, HIV/AIDS and poverty and health [30].
ICDDR,B is primarily a research institution, and it
maintains ongoing surveillance in regularly monitored
urban and rural communities, as well as conducting
laboratory research. It has a particular focus on a
research pathway of initial epidemiological research to
identify changes in population health; in depth studies
to identify causes and develop interventions; operational
Table 1 Areas of study, methods and data sources
Areas of Study Methods Data Sources
Context: perceived
problems and issues
Qualitative Interviews with ICDDR,B
management; key donors;
principal researchers
Quantitative Measurement of research output
and topics;
Financial analysis
Intervention Qualitative Interviews with ICDDR,B
management; key donors;
principal researchers
Discussion with M&E unit





Qualitative Interviews with ICDDR,B
management; key donors;
principal researchers
Discussion with M&E unit;
Discussion among authors
Quantitative Measurement of research output
Financial analysis
Impact externally Qualitative Interviews with Government of
Bangladesh policy makers;
collaborating research institutes;
other national and international
development agencies in
Bangladesh
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research on the implementation of interventions and
evaluation studies of their effectiveness. Examples
include the development of oral rehydration solution,
and zinc treatment for diarrhoea.
ICDDR,B also provides training in topics such as
research methods, clinical management of diarrhoeal
disease, laboratory methods, epidemiology and biostatis-
tics, family planning and demographic surveillance both
to its staff and to trainees from national, regional and
international institutions and individuals.
As part of its surveillance programme, and as a contri-
bution to the health of populations under surveillance,
ICDDR,B provides clinical services in the areas of its
expertise such as treatment of acute and persistent diar-
rhoea, nutrition rehabilitation of malnourished children,
treatment of acute respiratory infections, and treatment
of HIV-AIDS. The organisation also assists the agencies
of the Government of Bangladesh in investigating and
responding to outbreaks and epidemics of potentially
infectious disease.
Governed by a distinguished Board of Trustees (BOT)
comprising 17 multinational members, ICDDR,B’s devel-
opment is guided by a series of strategic plans, which
identify research priorities, and capacity building objec-
tives. The majority of its funding is provided as research
grants for specific projects, provided by donors or
through competitive process. A few donors, including
the Government of Bangladesh, the Australian Agency
for International Development (AusAID); the Canadian
International Development Agency (CIDA); the Depart-
ment for International Development (DFID) United
Kingdom; the Embassy of the Kingdom of the Nether-
lands (EKN); and the Swedish Agency for International
Development Cooperation (SIDA), provide funding for
specific infrastructure and capacity building activities,
not directly linked to research (core donors).
The 2006 Annual Review and Proposed changes
During the 2006 annual review of ICDDR,B, a number
of issues were identified, which were considered impor-
tant for the future development of research-based
funding.
ICDDR,B was receiving funding from around 55 dif-
ferent donors and research granting bodies, each with
their own specific research interests, financing rules and
regulations, and reporting requirements. At the same
time, the organisation’s need for funding the underlying
research infrastructure and administrative and manage-
ment systems (denoted as “core activities”) was growing.
In order to finance infrastructure development required
to maintain research projects for donor organisations,
ICDDR,B requested a 30% management levy from the
research donors. However, many were reluctant to make
this contribution and, in addition, this levy proved
unpopular with the organisation’s researchers who felt
that it made their proposals less competitive. Only a few
donors were prepared to contribute ‘unearmarked’ funds
or funding for specific aspects of core activities.
ICDDR,B management felt that it was constrained in
pursuing the research priorities identified in its strategic
plan and was being tied to the interests of research
donors. Furthermore, the organisation’s capacity to
invest in developing and maintaining the physical and
human resource infrastructure needed to support
research was limited.
In consultation with the organisation’s management
team and the small group of donors prepared to invest
in core activities, referred to as the Core Donor Group
(CDG), the 2006 review proposed a change in the way
ICDDR,B and its CDG interacted. This change involved
the following: the core donors agreed to provide ‘unear-
marked’ funding to ICDDR,B to support its infrastruc-
ture development and maintenance, and capacity
building; the organisation was required to report to the
core donors on the actual use of these funds through a
single annual financial report, and a single comprehen-
sive report of progress in achieving the agreed indicators
using a common Monitoring and Evaluation Framework
(MEF); and jointly, the organisation and its core donors
were to undertake an annual review of core fund use
reporting against the indicators in the MEF.
Monitoring and Evaluation Framework (MEF)
The development of the MEF was a key requirement for
the funding changes to be made and it provided the
agreed framework for core donor commitment, as well
as directing the future development of ICDDR,B, and
creating a tool allowing for measuring the progress. The
main challenge was in reconciling the interests and prio-
rities of the donors with those of ICDDR,B. The organi-
sation’s strategic plan (2001-2010) at that time focused
on identifying priority research areas, and provided little
guidance on the directions or extent of capacity or infra-
structure development, or on the expected outcomes
from research in those identified priority areas. The
CDG members were particularly interested in ensuring
that research addressed key policy issues for health sys-
tems in low and middle income countries (LMIC), and
that the research findings were communicated to policy
users and, where appropriate, influenced policy
decisions.
The MEF, which was developed and agreed in 2007,
addresses the four key areas of ICDDR,B’s commitment:
research, clinical services, teaching, and improvements
in management and operations. For each area, priority
outcomes, outputs and activities are nominated, with
indicators providing suitable measures. Where possible,
indicators are based on data already being collected at
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ICDDR,B, or where the organisation has the capability
to collect the required data. Where available, the out-
comes and outputs in the MEF refer to the priorities
and development targets outlined in the Strategic Plan
(Table 2), The MEF approach was cited with approval
in Morris et al 2008 and this can become a key element
of performance reporting for organizations [31].
The 2010 Annual review and changes identified
The annual external review of 2010 was extended to
assess the effect of the changes recommended in 2006
on ICDDR,B’s performance over the period 2007 to
2009 against the MEF indicators, and to evaluate, in
more depth, the contribution made by core funding to
the research carried out by ICDDR,B. The review identi-
fied the following changes:
Changes in the relationship between core donors and the
ICDDR,B
Both the core donors (CD) and ICDDR,B management
reported a significant ‘qualitative’ change in the relation-
ship between each other. The CD functioned more as a
coherent group, rather than individually, facilitating col-
lective communication and decision making. Frequent
communication and a good relationship with the chair
of the group of CD dramatically reduced the need for
multiple communications to each individual donor.
There had been a genuine attempt to maintain the
commitment to a single combined funding, and moni-
toring and evaluation (M&E) process, despite some
reservations. The single combined financial reporting
had been largely accepted, as well as the joint annual
M&E review.
ICDDR,B management reported that the reduction in
reporting from quarterly to annual, and a single rather than
multiple-reporting format for the core donors had reduced
transaction costs, and led to further progress towards har-
monised and convergent management and funding pro-
cesses. From this collaborative approach on behalf of the
CD, a single consolidated funding request process has been
established. Core donors also reported that the annual
reporting process and single pooled funding contribution
reduced their own costs in oversight and supervision.
Interviews with ICDDR,B managers noted a marked
change in terms of ownership and control, with ICDDR,
B demonstrating much greater capacity and ability to
control its own development, and preparedness to invest
core funds particularly in neglected areas in order to
build future capacity. This had not been possible in the
past, when development of research programmes and
capacity had been mainly ‘donor driven’.
The success of the first three years of the CD and
MEF has led to the development of a new strategic plan
for the period 2011-2020, which capitalizes on the posi-
tive outcomes of this new funding approach and incor-
porates the organisation’s priorities into the new
strategic plan with improved monitoring, evaluation and
reporting structures and processes.
Use of the MEF
The MEF has been used as the basis for annual report-
ing and reviews for the years 2007, 2008 and 2009, with
Table 2 Summary of outcomes and outputs from MEF
Level Research Clinical Services Training Operation &
Management
Outcomes New knowledge relevant to global
and local health needs
Changes in programs, policies and
practices which incorporate this
knowledge
Contribution to health of
populations served
Knowledge of service needs &
clinical interventions
Local and regional health/research
workforce have improved skills and
knowledge in relevant areas
Incorporation of knowledge into
practice
Growth and development
of ICDDRB in line with
vision and mission
Maintain relevance of
ICDDRB to local, regional
and national context
Outputs Research agenda which identifies
priority research areas & objectives
Program of research activities
which is:
(a) in line with priorities in
strategic plan (SP)
(b) sensitive to issues of gender,
environment, poverty, & equity
(c) credible and high quality
based on sound methodology &
innovation
(d) conducted according to ethical
standards with benefit for research
participants
Users and decision makers in
relevant areas informed of
research findings & implications
Effective treatment is provided
to patients
Equity in access to services
appropriate to need
Efficient use of resources in
provision of services
Quality of clinical services
maintained and risks to
patients and staff minimised
Research results and findings
relevant to clinical services
Training program based on workforce
needs and ICDDR,B areas of
contribution
Course participants have knowledge
and improved skills in relevant areas
Quality: Knowledge and skills based on
relevant evidence and effective
teaching methods
Increase in total and externally
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modifications being made on an on-going basis in line
with developments in the collection and compilation of
data, and new developments in services and research
interests.
The quality of reporting and the information provided in
the MEF report has improved progressively, and in the
2010 review, the 2009 data was either good or sufficient in
terms of performance assessment against 80% of related
indicators. The main weaknesses in reporting were exces-
sive detail, lack of focus on priority areas or significant
results, and lack of comparative analysis. Reporting against
outcomes, particularly in the areas of research and clinical
services, was found to be poor, and recommendations
were given as a means to strengthen this element.
However, the interviews found some differences in the
perception of managers and researchers (especially prin-
cipal investigators) regarding the MEF. While managers
saw the benefits in terms of savings in transaction costs,
and greater autonomy in use of funds, researchers
tended to view it as an additional donor requirement
and of little benefit to them personally. It was clear that
some of this alienation was due to ICDDR,B’s existing
structure. With this in mind, the new Strategic Plan
2020 includes a significant restructuring to better align
researchers with the strategic priorities of the organisa-
tion, and their reporting with the MEF.
Performance in key areas of research, clinical services,
training and capacity building, management, and
operations
The review found that ICDDR,B has continued to per-
form well in all areas (Table 3). In terms of research,
the review documented significant research findings,
and incorporation of these findings into international
policy and national programme guidelines in five of the
priority research areas, as described in the Strategic
Plan, 2001-2010. In particular, the interviews with exter-
nal stakeholders identified that ICDDR,B researchers
employed a range of mechanisms for disseminating
information and policy engagement, and that building
relationships between researchers and policy makers had
been key to influencing policy in the complex and
dynamic political environment of Bangladesh.
The number of patients treated through clinical ser-
vices increased while there were also improvements in
the range of services and standard of care provided.
Increases in the number and range of training provided,
particularly for ICDDR,B staff and for GoB agencies,
Table 3 Research outcomes and key indicators and achievement
Outcome/output Indicators Achievement (2009)
Outcome
1. New knowledge relevant to global and local
health needs
Implications of research findings or results for
current knowledge/understanding or programs/
interventions in relation to MDGs or national
priorities.
Review of progress and policy development
demonstrates significant contributions in 6/8
priority areas of Strategic Plan 2001-2010
2. Changes in programs, policies and practices
which incorporate this knowledge
Changes in national/regional or international
policy/programs consistent with new knowledge/
research findings.
Significant policy changes/policy
contribution in 5/8 priority areas of Strategic
Plan 2001-2010
Outputs
1. Updated research agenda which identifies
priority research areas & objectives
Revisions to the priority research areas based on
consultation with stakeholders and research
findings undertaken at least every 2 years.
Strategic Plan 2010-2020 provides
information on new research directions and
justification
2. Program of research protocols and research
activities which contribute to the objectives in
the priority research areas identified in the
Strategic Plan
Number of new research protocols/activities
approved by research priority area and research
phase during the last 12 months
Increase in infections (27%), health systems
(17%); decrease in diarrhoea (9%) and HIV
(8%)
Shift towards operational research
3. Research program addresses issues of gender,
environment, poverty and equity where relevant.
No/% of protocols approved during the last 12
months which address - gender, environment,
poverty and equity.
Very low proportions - no significant change
over 2007-2009 periods. Reporting is not
capturing this information.
4. Research undertaken by ICDDR,B is regarded as
high quality and innovative by international
peers.
No. of publications in the high impact peer
reviewed journals by research priority area during
last 12 months.
Most in traditional strong areas of diarrhoea
(1/3), infections, child health
No. of citations in peer reviewed literature for key
publications in each priority research area over a 5
year period.
Citation rate by area:
highest in diarrhoea (7.3); infectious disease
(4.9); child health (4.5)
5. Research undertaken by ICDDR,B is conducted
according to ethical standards
Presence of policies on scientific misconduct,
acknowledgement, authorship, sex trafficking,
allocation core funds
Policies established, but compliance not
known
Numbers and proportion of investigators certified
for human research
Proportion has risen to 97% from low levels
in previous years
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were also highlighted in the review. The number trained
in research skills increased from 36 in 2007 to 120 in
2009 with 40% of participants being female, while the
number trained in clinical skills remained between 120
and 130 per year, with the proportion of female trainees
increasing from 20% to 30%.
In the area of management and operations, ICDDR,B
achieved two of the six priorities identified in the 2001-
2010 Strategic Plan, namely reaching the financial target
of US$30 million annual gross income; and the intro-
duction of a computerised financial management system.
The remaining four priorities appeared to be making
significant progress, including introduction of IT appli-
cations, extension of the main ICDDR,B building to 8
floors, and transition in HR management from the UN
system to a competency-based system.
There was significant progress in the area of human
resource management, with the establishment of an HR
development unit, the development and implementation
of a specific gender policy, an assessment of organisa-
tion-wide training needs, and the expansion of training
provided to staff in identified priority areas: English lan-
guage; computer applications; and scientific writing.
Contribution of core funds to ICDDR,B
Against continuing increases in total funding for the
organisation, which increased from $23.15 million to
$38.69 million between 2006 and 2009, the proportion
of total revenue represented by core funds increased
from 25% to nearly 40%, a figure that has since
remained relatively steady. Total core donor funding in
2009 was $14,099,000 of which the CD contributed
$13,070,000 (94%) At the same time research grant and
project income has also increased, from $13.3 million in
2006, to $23.1 million in 2010, an increase of nearly
75% (Table 4).
There were some changes in relationships with other
donors that contributed to this improved financial per-
formance, including agreement by the Government of
Bangladesh to provide funding for new capital works,
and to channel funding from the Health Sector Support
Project to ICDDR,B; and relaxation in the requirements
for funding from USAID that enabled ICDDR,B to
receive USAID funding after a period when family plan-
ning restrictions had prevented it.
Total core expenditure, including core capital expendi-
ture, increased by 31% between 2007 and 2009. The
amount contributed by core donor funding rose slightly
from 78% in 2007 to 81% in 2009; the remaining 19-
20% was derived from management levies, research pro-
ject funds, and other receipts. The 80% core expenditure
covered by CD funds comprises a combination of opera-
tional/recurrent expenditure, plus investment in new
systems, processes and equipment (Table 4).
Core funds have also been used to support research in
new areas while research proposals and capacity build-
ing are being encouraged and developed (e.g. in health
systems). Direct funding of research from core funds
remains relatively small at only 5% of total research
funds, and focuses more on those areas for which
research grants are difficult to attract; strategic pilot or
‘seed’ research, which has attracted grants at a later
stage; and building capacity of young career researchers.
Principally, core funds were allocated to build research
infrastructure, in terms of systems, human resources,
and equipment. This is a key area in which it was pre-
viously difficult for ICDDR,B to invest, due to the con-
straints imposed by specific research project funding.
However, the core contribution has significantly
improved ICDDR,B’s future capacity to retain and
develop new researchers, and to compete for and gain
competitive research grants
Discussion
While this review only documented changes over a three
year period, it suggests that the changes to the funding
and reporting arrangements between the core donors
and ICDDR,B has had a significant impact on the pro-
blems identified in the 2006 review.
In particular, ICDDR,B management feels that the new
funding arrangement has increased autonomy to pursue
its identified strategic priorities; has enabled the organisa-
tion to invest in research infrastructure and workforce
capacity development; and has maintained its success in
obtaining research grants and project funding. These
investments have focused on human resource develop-
ment at ICDDR,B, which is consistent with the literature,
with development of ‘the capabilities of scientists to
undertake quality research’ being one of the two elements
of research capacity building identified by Nchinda [10].
Table 4 Revenue and expenditure by year (USD ‘000)
Revenue type 2006 2007 2008 2009
Research projects 13,307 16,674 20,906 23,065
Un-earmarked core funds 7,205 10,393 11,782 14,099
Other* 2,638 1,820 1,953 1,530
Total** 23,150 28,887 34,642 38,694
Operating Expenditure**
Research projects 13307 16674 20906 23065
Core funded research 301 895 804 964
Clinical services 2238 2747 4315 5323
Management systems 2747 4019 2906 3292
Infrastructure/research support/capacity
building
3390 5227 5179 5718
Total 21983 28756 34450 38598
*Includes management levy from research funding
** Excludes capital expenditure.
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The use of core funds as ‘seed’ funds for developing
research proposals is one way that ICDDR,B has
addressed the problem alluded to by Sitthi-amorn and
Somrongthong [9] as “the ‘brain drain’ of scientists and
researchers to developed countries”. The seed funds
enabled returning PhD students to commence their
careers as researchers, without having to wait until they
could win research grants through their own initiatives.
There have also been efficiency savings in terms of
reduction in multiple reporting and communication
with multiple donors, and continued growth in total rev-
enue from both research grants and core funding. While
other changes in the operating context such as the
increased funding from the Government of Bangladesh
and USAID clearly contributed, it is likely that the
increased investment in infrastructure and human
resources assisted ICDDR,B in responding to these new
opportunities.
The effectiveness of the core funding mechanism is
dependent on a common and agreed strategy, and an
effective MEF to measure, monitor and evaluate pro-
gress in achieving the strategic elements. Establishing
such a framework in the context of a research institute
is challenging, as researchers traditionally value auton-
omy in pursuing their research objectives, rather than
being guided by institutional strategy and key perfor-
mance indicators.
While the principal focus of the MEF has been on
reporting to donors, ICDDR,B management have been
keen to use the MEF to improve monitoring and report-
ing within the organisation on achievement of the Stra-
tegic Plan priorities. The establishment of the M&E
Unit, and the regular annual reviews have imposed addi-
tional costs on both ICDDR,B and donors, but also
enabled them to periodically revise and improve the
MEF.
Authors of other published articles have commented
on the difficulty of identifying appropriate indicators
for measuring research capacity building. Commonly
measured outcomes include publications in peer-
reviewed journals, successful grant applications, qualifi-
cations of the researchers, projects per year, projects
per researcher, project duration of greater than one
year, and conference presentations [3,25,28,32]. As
Cooke (2005) noted, these ‘traditional outcomes may
not address all the relevant issues to highlight progress’
in research capacity building. In particular, she notes
the need to address the supportive environment, use-
fulness or social impact of research, and professional
outcomes [32].
The experience at ICDDR,B confirms the importance
of an agreed MEF, with indicators that capture the full
breadth of the organisation’s activities, and are sensitive
to the capacity building efforts. The elements of the
MEF reflect the six principles proposed by Cooke (2005)
[32]: developing skills and confidence; supporting links
and partnerships; ensuring that research is ‘close to
practice’; developing appropriate dissemination; invest-
ing in infrastructure; and building elements for sustain-
ability and continuity. ICDDR,B’s clinical services
provide the opportunity for research that is ‘close to
practice’, while the management and operations’ section
addresses infrastructure, and sustainability and
continuity.
Conclusions
While this paper reports on the experience of one
research institute in a developing country context, there
are three key issues which we believe are of relevance to
other institutes in similar contexts:
(1) Investment in capacity building and maintaining
physical and human resource infrastructures of research
institutes is vital to their sustained operation. However,
adequate funding for these needs cannot be obtained
through funding for specific research projects or
through research grants, even with a ‘management levy’.
(2) Part of this capacity is the ability and autonomy of
the research institute to determine its own strategic
growth and research priorities, and to invest in pursuing
these, rather than the priorities determined by research
funders.
(3) The provision of unearmarked core funding for use
by the research institute to invest in the agreed strategic
priorities is a potential mechanism to build this capacity
and to maintain this autonomy. In many ways, this
situation is comparable to that of the governments of
low income countries when dealing with donors, with
the process established at ICDDR,B has been likened to
a ‘mini SWAPs (Sector Wide Approaches)’, consistent
with the principles of the Paris Declaration on Aid
Effectiveness [33].
However, as in SWAps, there is a need for significant
capacity on the part of the research institute to manage
and operate such a mechanism. This includes the devel-
opment of its own strategic plan and identification of
investment priorities; the ability to manage and report
on use of the funds in a financially accountable manner;
and the ability to report on results through an agreed
M&E framework. Underlying this is the need for confi-
dence and a strong relationship between the research
institute and its donors, that allows for robust dialogue
and the resolution of differences.
ICDDR,B has been fortunate in having a long period
of interaction with donors prior to the establishment of
this mechanism in which to build up this capacity, and
to develop these relationships.
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